Published in Biochim Biophys Acta on August 24, 2017
Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J (1979) 8.95
Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). J Biol Chem (1998) 3.78
Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology (2010) 3.11
Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis. Hepatology (2012) 2.62
PHLiPPing the switch on Akt and protein kinase C signaling. Trends Endocrinol Metab (2008) 1.92
Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases. Liver Int (2008) 1.87
Glycerolipid metabolism and signaling in health and disease. Endocr Rev (2008) 1.80
PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice. J Clin Invest (2008) 1.55
Gadd45 in stress signaling. J Mol Signal (2008) 1.42
Death receptor 5 signaling promotes hepatocyte lipoapoptosis. J Biol Chem (2011) 1.23
ATF-2 controls transcription of Maspin and GADD45 alpha genes independently from p53 to suppress mammary tumors. Oncogene (2007) 1.18
Polyenephosphatidylcholine prevents alcoholic liver disease in PPARalpha-null mice through attenuation of increases in oxidative stress. J Hepatol (2009) 1.16
Metabolomics. Cell Metab (2007) 1.09
Dimethylbenzanthracene carcinogenesis in Gadd45a-null mice is associated with decreased DNA repair and increased mutation frequency. Cancer Res (2001) 1.08
Nrf2 protection against liver injury produced by various hepatotoxicants. Oxid Med Cell Longev (2013) 1.07
Role of white adipose lipolysis in the development of NASH induced by methionine- and choline-deficient diet. Biochim Biophys Acta (2014) 1.03
Metabolomics identifies an inflammatory cascade involved in dioxin- and diet-induced steatohepatitis. Cell Metab (2012) 1.01
Functions of galectin-3 and its role in fibrotic diseases. J Pharmacol Exp Ther (2014) 0.99
Down-regulation of SREBP-1c is associated with the development of burned-out NASH. J Hepatol (2010) 0.96
Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet. Biochim Biophys Acta (2015) 0.95
Disruption of endothelial peroxisome proliferator-activated receptor γ accelerates diet-induced atherogenesis in LDL receptor-null mice. Arterioscler Thromb Vasc Biol (2011) 0.92
Non-alcoholic steatohepatitis: the role of oxidized low-density lipoproteins. J Hepatol (2012) 0.91
Controlled attenuation parameter is correlated with actual hepatic fat content in patients with non-alcoholic fatty liver disease with none-to-mild obesity and liver fibrosis. Hepatol Res (2016) 0.83
Gadd45 in the liver: signal transduction and transcriptional mechanisms. Adv Exp Med Biol (2013) 0.81
Steatogenesis in adult-onset type II citrullinemia is associated with down-regulation of PPARα. Biochim Biophys Acta (2014) 0.80
The molecular basis of leukocyte adhesion involving phosphatidic acid and phospholipase D. J Biol Chem (2014) 0.79
Selective inhibition of activated stellate cells and protection from carbon tetrachloride-induced liver injury in rats by a new PPARgamma agonist KR62776. Arch Pharm Res (2010) 0.79
New role and molecular mechanism of Gadd45a in hepatic fibrosis. World J Gastroenterol (2016) 0.77
Insufficiency of phosphatidylethanolamine N-methyltransferase is risk for lean non-alcoholic steatohepatitis. Sci Rep (2016) 0.76
Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet. Biochim Biophys Acta (2015) 0.95
Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy. BBA Clin (2015) 0.78
PPARα protects against trans-fatty-acid-containing diet-induced steatohepatitis. J Nutr Biochem (2016) 0.75